The Association of Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate with Obesity, Waist-hip Ratio, and Insulin Resistance in Postmenopausal Women
Journal Title: Turkish Journal of Endocrinology and Metabolism - Year 1999, Vol 3, Issue 2
Abstract
Recent studies revealed that oral dehydroepiandrosterone (DHEA) reduced weight gain in genetically obese mice without affecting their food intake. We aimed to compare the association of DHEA and dehydroepiandrosterone sulfate (DHEAS) levels with obesity, fat distribution and insulin resistance in different groups of postmenopausal women. Thirty postmenopausal women were divided into age-matched three groups; Group-I: 10 obese women with Type II diabetes mellitus, group-II: 10 obese women without diabetes, group III: (Controls); 10 nonobese and nondiabetic women. Body mass index (BMI), waist-hip ratio (WHR), and insulin resistance (by hyperinsulinemic euglycemic clamp studies) were calculated in all groups. Plasma DHEA and DHEAS levels were also measured. Women in group-I and II had significantly higher WHR than control women, indicating central deposition of body fat (p=0.039, p=0.041 respectively). As expected, insulin resistance was most significant in obese and diabetic women (group-I). Following them obese but nondiabetic women (group-II) had more insulin resistance than women without obesity and diabetes (group-III). DHEA and DHEAS levels of women with obesity and diabetes (group-I) were greater than those of group-II and group-III. Group-III had the lowest DHEA and DHEAS levels in all women. DHEA and DHEAS were positively correlated with both BMI and WHR. However, glucose disposal rate was inversely and significantly correlated with DHEA and DHEAS levels. These data do not support the hypothesis that DHEA or DHEAS protect postmenopausal women against diabetes and obesity. These findings suggest that increasing levels of DHEA and DHEAS may be associated with weight gain, central obesity and reduced insulin sensitivity.
Authors and Affiliations
Murat Saruç, Bilgin Özmen, Bülent Kılıççıoğlu
Keywords
Related Articles
- EP ID EP83180
- DOI -
- Views 144
- Downloads 0
The Effects of Growth Hormone Therapy on Echocardiographic Parameters in Growth Hormone Deficient (GDH) Patients
Ideas about hormone replacement therapy in hypopituitarism have changed since the discovery of increased atheroscferotic process caused by growth hormone (GH) deficiency.The aim of this study is to see the effect of GH t...
Spontaneous Remission of Acromegaly Due to Apoplexy
Pituitary apoplexy is a rare clinical syndrome characterized by sudden onset of headache and vomiting, accompanied by visual disturbance or ocular motility impairment and pituitary insufficiency. Pituitary apoplexy prese...
Twice Weekly L-T4 for the Treatment of Primary Hypothyroidism
This study was done to see whether levothyroxine (L-T4) given twice a week is effective and safe in the management of primary hypothyroidism in 20 patients with primary hypothyroidism who were followed by the outpatient...
Ghrelin
Growth hormone secretagogues are synthetic peptidyl and non- peptidyl molecules that possess growth hormone releasing activity. Ghrelin is an endogenous natural ligand for the growth hormone secretagogue receptor that ha...
Correlations of Serum Cu+2, Zn+2, Mg+2 and HbA1c in Type 2 and Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus (DM) is one of the most frequently seen. Type 2 DM shows identical patophysiological features with Type 1 DM but differs in etiology. There are lots of studies in the area of both types of DM whi...